Citragen Pharmaceuticals

What Citragen Pharmaceuticals does

Citragen Pharmaceuticals is a privately held U.S. pharmaceutical manufacturer based in Fremont, California, founded in 2014. The company's core business is the manufacture and supply of basic pharmaceutical products — specifically calcium carbonate, sodium bicarbonate, and sodium chloride tablets. These inputs are typical of antacid, calcium supplement, electrolyte replacement, and pharmaceutical formulation applications, indicating that Citragen operates in the generic/OTC pharmaceutical ingredient and finished-dose segment.

The company is small, with 11–50 employees, and is led by founder Ravi Jayapal, who serves as Co-Founder, CEO and President. Public information about its technology stack, manufacturing facilities, certifications, customer base, distribution channels, and financials is not disclosed in the available data; the company's website currently resolves to a CAPTCHA verification page rather than substantive content.

Given the limited data, the business model appears to be straightforward contract or generic pharmaceutical manufacturing, generating revenue through the sale of commodity tablet products to wholesale, distributor, or healthcare-buyer channels. No pricing model, GTM motion, or customer segmentation details are documented in the input.

Name

Citragen Pharmaceuticals

Website

https://citragenpharma.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Citragen Pharmaceuticals is a small U.S. pharmaceutical manufacturer founded in 2014 and based in Fremont, California, producing and supplying calcium carbonate, sodium bicarbonate, and sodium chloride tablets for healthcare and consumer health applications.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYCRADAGAF

Probiotics & Digestive Health Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAC

Multivitamins & Daily Packs

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

Keywords

• Pharmaceutical manufacturing
• Tablet formulation
• Generic pharmaceuticals
• Calcium carbonate tablets
• Active ingredients

Headquarters

HQ city

Fremont

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Core offering

CitraGen Pharmaceuticals manufactures and supplies pharmaceutical tablet products, including calcium carbonate tablets, sodium bicarbonate tablets, and sodium chloride tablets. The company operates as a small-scale for-profit pharmaceutical manufacturer based in Fremont, United States, producing these tablet formulations for downstream pharmaceutical and healthcare buyers.

Differentiator

Problem solved

Functional benefit

Products and services

• Calcium Carbonate Tablets Calcium carbonate tablet product manufactured and supplied by Citragen Pharmaceuticals.
• Sodium Bicarbonate Tablets Sodium bicarbonate tablet product manufactured and supplied by Citragen Pharmaceuticals.
• Sodium Chloride Tablets Sodium chloride tablet product manufactured and supplied by Citragen Pharmaceuticals.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Direct peers

• ANI Pharmaceuticals: US-based specialty generic pharmaceutical manufacturer producing finished dosage forms (tablets, capsules, liquids). Directly comparable as a small/mid-cap generic drug manufacturer serving retail, hospital, and institutional channels.
• Lannett Company: Generic pharmaceutical manufacturer focused on oral solid dose products including tablets and capsules. Comparable as a US-based finished-dose generic manufacturer with similar channel exposure.
• Saptalis Pharmaceuticals: Specialty generic pharmaceutical company focused on liquid, semi-solid, and oral solid dose generics. Comparable as a smaller, niche-focused generic manufacturer pursuing contract and private-label opportunities.
• Novitium Pharma: US-based specialty generic pharmaceutical company developing and manufacturing oral solid and liquid dosage forms. Comparable as a focused, smaller-scale generic manufacturer with similar channel and customer profile.
• Bayshore Pharmaceuticals: US specialty pharmaceutical company specializing in generic oral solid and other dosage forms. Comparable as a smaller, niche-focused finished-dose manufacturer.

Broad incumbents

• Amneal Pharmaceuticals: Large-scale generic and specialty pharmaceutical manufacturer with a broad portfolio of oral solid and injectable products. Comparable as an established player in the same generic tablet manufacturing space with broader portfolio reach.
• Apotex: One of the largest Canadian generic pharmaceutical manufacturers producing tablets, capsules, and other dosage forms at scale. Comparable as a high-volume generic tablet producer serving US distribution channels.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a vast portfolio of oral solid and other dosage forms. Comparable at the category level for generic mineral and basic preparation tablets.
• Padagis: Specialty generics and consumer health manufacturer offering a broad OTC and prescription portfolio including tablets. Comparable as a manufacturer serving OTC and private-label channels with mineral and supplement preparations.
• Dr. Reddy's Laboratories: Global pharmaceutical manufacturer with a large generics portfolio including oral solids. Comparable category-wise as a manufacturer of commodity generic preparations including mineral-based products.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/citragen-pharmaceuticals-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Citragen Pharmaceuticals